Evidence map›Paper›PMID 42041124›Full record

ArticleACS applied materials & interfaces2026

Combinatorial Design of Slippery, Nitric Oxide-Releasing Surfaces Incorporating Copper Nanoparticles for Blood-Contacting Devices.

Vicente D Pinon, Mark Garren, Yi Wu, Grace H Nguyen, Elizabeth J Brisbois, Hitesh Handa

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vicente D PinonDepartment of Pharmaceutical & Biomedical Sciences, University of Georgia, Athens, Georgia 30602, United States.
Mark GarrenSchool of Chemical, Materials, and Biomedical Engineering, College of Engineering, University of Georgia, Athens, Georgia 30602, United States.ORCID 0000-0001-5194-6558
Yi WuSchool of Chemical, Materials, and Biomedical Engineering, College of Engineering, University of Georgia, Athens, Georgia 30602, United States.
Grace H NguyenSchool of Chemical, Materials, and Biomedical Engineering, College of Engineering, University of Georgia, Athens, Georgia 30602, United States.ORCID 0009-0009-2939-8394
Elizabeth J BrisboisSchool of Chemical, Materials, and Biomedical Engineering, College of Engineering, University of Georgia, Athens, Georgia 30602, United States.ORCID 0000-0002-9283-5448
Hitesh HandaDepartment of Pharmaceutical & Biomedical Sciences, University of Georgia, Athens, Georgia 30602, United States.ORCID 0000-0002-9369-7374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hospital acquired infections (HAIs) remain a prevailing issue in clinical settings. These challenges are associated with the health and economic burdens of complications such as bloodstream infections, biomedical device fouling, and antimicrobial resistance. Nitric oxide (NO) is an endogenous gasotransmitter that has vasodilatory, antimicrobial, and antiplatelet effects. This has allowed NO to surface as a potential bioactive strategy for integration into medical device technologies. When combined with other surface modifications, such as liquid infusion (LI) and copper nanoparticles(CuNPs), this approach yields slippery, antifouling surfaces with dual antibacterial and NO-catalysis properties. Herein, we combined

Indexed as

Anti-Bacterial AgentsCopperMetal NanoparticlesNitric OxideNitric Oxide DonorsEscherichia coliHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsS-Nitroso-N-AcetylpenicillamineSurface PropertiesAnti-Bacterial AgentsCopperNitric OxideNitric Oxide DonorsS-Nitroso-N-Acetylpenicillamineantibacterialcopper nanoparticlesliquid infusionnitric oxide

Identifiers

PMID42041124
PMCPMC13154129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.